С. Е. Титов

742 total citations
59 papers, 504 citations indexed

About

С. Е. Титов is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, С. Е. Титов has authored 59 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Cancer Research and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in С. Е. Титов's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (19 papers) and Thyroid Cancer Diagnosis and Treatment (17 papers). С. Е. Титов is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (19 papers) and Thyroid Cancer Diagnosis and Treatment (17 papers). С. Е. Титов collaborates with scholars based in Russia, United States and Australia. С. Е. Титов's co-authors include Mikhail Ivanov, N. N. Kolesnikov, И. Ф. Жимулев, Anastasia Malek, П. С. Деменков, L. F. Gulyaeva, R. B. Samsonov, А. В. Кочетов, D. Vasilyev and Tatiana Shtam and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

С. Е. Титов

52 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
С. Е. Титов Russia 12 284 244 121 74 43 59 504
Stephanie Oerum France 11 703 2.5× 267 1.1× 30 0.2× 13 0.2× 20 0.5× 14 766
Fudi Zhong China 14 485 1.7× 346 1.4× 13 0.1× 77 1.0× 78 1.8× 24 711
Shengbin Dai China 12 291 1.0× 118 0.5× 11 0.1× 23 0.3× 38 0.9× 28 490
Bogomir Dimitrijević Serbia 13 202 0.7× 92 0.4× 31 0.3× 18 0.2× 10 0.2× 32 367
Yongjia Tong China 9 193 0.7× 83 0.3× 59 0.5× 10 0.1× 36 0.8× 15 329
Soichiro Ando Japan 11 150 0.5× 57 0.2× 21 0.2× 13 0.2× 18 0.4× 26 399
Mei Yieng Chin Canada 14 367 1.3× 152 0.6× 31 0.3× 15 0.2× 39 0.9× 19 516
M. Haq United Kingdom 8 150 0.5× 139 0.6× 45 0.4× 5 0.1× 51 1.2× 11 405
Haojun Xu China 15 293 1.0× 148 0.6× 15 0.1× 7 0.1× 68 1.6× 40 473
Hongyang Huang China 9 649 2.3× 497 2.0× 8 0.1× 10 0.1× 52 1.2× 14 758

Countries citing papers authored by С. Е. Титов

Since Specialization
Citations

This map shows the geographic impact of С. Е. Титов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by С. Е. Титов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites С. Е. Титов more than expected).

Fields of papers citing papers by С. Е. Титов

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by С. Е. Титов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by С. Е. Титов. The network helps show where С. Е. Титов may publish in the future.

Co-authorship network of co-authors of С. Е. Титов

This figure shows the co-authorship network connecting the top 25 collaborators of С. Е. Титов. A scholar is included among the top collaborators of С. Е. Титов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with С. Е. Титов. С. Е. Титов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Титов, С. Е., et al.. (2024). Multiple Myeloma: Genetic and Epigenetic Biomarkers with Clinical Potential. International Journal of Molecular Sciences. 25(24). 13404–13404.
2.
Титов, С. Е., et al.. (2024). Could SLC26A7 Be a Promising Marker for Preoperative Diagnosis of High-Grade Papillary Thyroid Carcinoma?. Diagnostics. 14(23). 2652–2652. 1 indexed citations
3.
Титов, С. Е., et al.. (2024). Prediction of the Aggressive Clinical Course of Papillary Thyroid Carcinoma Based on Fine Needle Aspiration Biopsy Molecular Testing. International Journal of Molecular Sciences. 25(13). 7090–7090. 3 indexed citations
4.
Титов, С. Е., et al.. (2023). Problems of follicular thyroid carcinoma diagnostics. SHILAP Revista de lepidopterología. 13(3). 10–23.
5.
Титов, С. Е., et al.. (2022). Reference Genes for qPCR-Based miRNA Expression Profiling in 14 Human Tissues. Medical Principles and Practice. 31(4). 322–332. 11 indexed citations
6.
Титов, С. Е., et al.. (2022). Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer. PLoS ONE. 17(2). e0254304–e0254304. 7 indexed citations
7.
Титов, С. Е., et al.. (2021). New opportunities for preoperative diagnosis of anaplastic thyroid cancer. SHILAP Revista de lepidopterología. 11(1). 34–40. 1 indexed citations
8.
Ivanov, Mikhail, et al.. (2021). Detection of Cervical Lesions and Cancer in Air-Dried Cytologic Smears by Combined Analysis of mRNA and miRNA Expression Levels. Journal of Molecular Diagnostics. 23(5). 541–554. 8 indexed citations
9.
10.
Титов, С. Е., et al.. (2020). DIFFERENTIAL DIAGNOSTICS OF GASTRIC CANCER AND PRECANCEROUS CHANGES OF THE GASTRIC MUCOSA USING ANALYSIS OF EXPRESSION OF SIX MICRORNAS. Russian Clinical Laboratory Diagnostics. 65(2). 131–136. 5 indexed citations
11.
Титов, С. Е., et al.. (2020). Stratification of papillary thyroid cancer relapse risk based on the results of molecular genetic studies. SHILAP Revista de lepidopterología. 10(1). 93–100. 3 indexed citations
12.
13.
Титов, С. Е., et al.. (2020). Prospects of Molecular Genetic Panels Use in the Preoperative Differential Diagnosis of Nodular Lesions of the Thyroid Gland. Novosti hirurgii. 28(3). 284–289. 1 indexed citations
14.
15.
Титов, С. Е., et al.. (2018). MicroRNAs – promising molecular markers for detecting cancer in thyroid nodules. SHILAP Revista de lepidopterología. 14(3). 140–148. 3 indexed citations
16.
17.
Samsonov, R. B., Tatiana Shtam, Mikhail Ivanov, et al.. (2017). EVALUATION OF EXPRESSION OF 4 MIRNAS IN CYTOLOGICAL SAMPLES AS AN ADDITIONAL METHOD OF CERVICAL CANCER DIAGNOSIS. Tumors of female reproductive system. 13(3). 63–72. 3 indexed citations
18.
Samsonov, R. B., Vladimir Burdakov, Tatiana Shtam, et al.. (2017). ANALYSIS OF A MIRNA SET (MIR-21, -181A, AND -146A) AS A METHOD OF DIFFERENTIAL DIAGNOSIS OF THYROID NODULES. Head and neck tumors (HNT). 7(2). 16–24. 1 indexed citations
19.
Samsonov, R. B., Vladimir Burdakov, Tatiana Shtam, et al.. (2016). Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer. Tumor Biology. 37(9). 12011–12021. 95 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Oerum Breakdown of academic impact, for papers by Fudi Zhong Breakdown of academic impact, for papers by Shengbin Dai Breakdown of academic impact, for papers by Bogomir Dimitrijević Breakdown of academic impact, for papers by Yongjia Tong Breakdown of academic impact, for papers by Soichiro Ando Breakdown of academic impact, for papers by Mei Yieng Chin Breakdown of academic impact, for papers by M. Haq Breakdown of academic impact, for papers by Haojun Xu Breakdown of academic impact, for papers by Hongyang Huang
Rankless by CCL
2026